Literature DB >> 25911239

Radiation triggering immune response and inflammation.

Nezih Hekim1, Zafer Cetin2, Zacharenia Nikitaki3, Aysegul Cort4, Eyup Ilker Saygili5.   

Abstract

Radiation therapy (RT) is a well-established but still under optimization branch of Cancer Therapy (CT). RT uses electromagnetic waves or charged particles in order to kill malignant cells, by accumulating the energy onto these cells. The issue at stake for RT, as well as for any other Cancer Therapy technique, is always to kill only cancer cells, without affecting the surrounding healthy ones. This perspective of CT is usually described under the terms "specificity" and "selectivity". Specificity and selectivity are the ideal goal, but the ideal is never entirely achieved. Thus, in addition to killing healthy cells, changes and effects are observed in the immune system after irradiation. In this review, we mainly focus on the effects of ionizing radiation on the immune system and its components like bone marrow. Additionally, we are interested in the effects and benefits of low-dose ionizing radiation on the hematopoiesis and immune response. Low dose radiation has been shown to induce biological responses like inflammatory responses, innate immune system activation and DNA repair (adaptive response). This review reveals the fact that there are many unanswered questions regarding the role of radiation as either an immune-activating (low dose) or immunosuppressive (high dose) agent.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Danger signals; Immune response; Inflammation; Ionizing radiation; Low doses; Programmed cell death

Mesh:

Year:  2015        PMID: 25911239     DOI: 10.1016/j.canlet.2015.04.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

Review 1.  Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.

Authors:  B Farhood; N H Goradel; K Mortezaee; N Khanlarkhani; E Salehi; M S Nashtaei; H Mirtavoos-Mahyari; E Motevaseli; D Shabeeb; A E Musa; M Najafi
Journal:  Clin Transl Oncol       Date:  2018-08-22       Impact factor: 3.405

2.  A Serum Small Molecule Biosignature of Radiation Exposure from Total Body Irradiated Patients.

Authors:  Evagelia C Laiakis; Evan L Pannkuk; Siddheshwar Kisan Chauthe; Yi-Wen Wang; Ming Lian; Tytus D Mak; Christopher A Barker; Giuseppe Astarita; Albert J Fornace
Journal:  J Proteome Res       Date:  2017-08-31       Impact factor: 4.466

Review 3.  Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.

Authors:  Peter Vaupel; Gabriele Multhoff
Journal:  Strahlenther Onkol       Date:  2016-03-09       Impact factor: 3.621

Review 4.  Melatonin as an anti-inflammatory agent in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; A H Rezaeyan; A Salajegheh; S Rezapoor
Journal:  Inflammopharmacology       Date:  2017-03-02       Impact factor: 4.473

5.  NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.

Authors:  Qiuji Wu; Awatef Allouch; Audrey Paoletti; Celine Leteur; Celine Mirjolet; Isabelle Martins; Laurent Voisin; Frédéric Law; Haithem Dakhli; Elodie Mintet; Maxime Thoreau; Zeinaf Muradova; Mélanie Gauthier; Olivier Caron; Fabien Milliat; David M Ojcius; Filippo Rosselli; Eric Solary; Nazanine Modjtahedi; Eric Deutsch; Jean-Luc Perfettini
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

6.  An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontin.

Authors:  Ashley C Kramer; Yuliana Astuti; Alexis Elfstrum; Michael J Lehrke; Jakub Tolar; Bruce R Blazar; Amanda L Blake; Mandy E Taisto; Justin W Furcich; Erin E Nolan; Wilaiwan W Durose; Beau R Webber; Athena Geisness; David K Wood; Troy C Lund
Journal:  Blood Adv       Date:  2021-09-28

7.  Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy.

Authors:  Akanchha Mani Tripathi; Shahanshah Khan; Nabo Kumar Chaudhury
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

8.  Impaired post-irradiation survival of cyclooxygenase-2-deficient mice.

Authors:  M Hofer; Z Hoferová; A Gruzdev; L Dušek; M Falk
Journal:  Physiol Res       Date:  2018-07-25       Impact factor: 1.881

9.  Recent exposure to particle radioactivity and biomarkers of oxidative stress and inflammation: The Framingham Heart Study.

Authors:  Wenyuan Li; Marguerite M Nyhan; Elissa H Wilker; Carolina L Z Vieira; Honghuang Lin; Joel D Schwartz; Diane R Gold; Brent A Coull; Abdulaziz Mansour Aba; Emelia J Benjamin; Ramachandran S Vasan; Petros Koutrakis; Murray A Mittleman
Journal:  Environ Int       Date:  2018-10-28       Impact factor: 9.621

10.  Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas.

Authors:  Derui Yan; Qi Zhao; Zixuan Du; Huijun Li; Ruirui Geng; Wei Yang; Xinyan Zhang; Jianping Cao; Nengjun Yi; Juying Zhou; Zaixiang Tang
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.